TTD | Drug: D07OWC

Drug General Information
Drug ID	D07OWC
Former ID	DIB006088
Drug Name	OntecizumabAmatuximab
Synonyms	Ontecizumab
Drug Type	Antibody
Indication	Colorectal cancer [ICD9: 153, 154; ICD10:C18-C21]		Phase 1	[533072]
Company	Morphotek
Target and Pathway
Target(s)	Endosialin	Target Info		[551161]
References
Ref 533072	Phase I study of amatuximab, a novel monoclonal antibody to mesothelin, in Japanese patients with advanced solid tumors. Invest New Drugs. 2015 Apr;33(2):380-8.
Ref 551161	Clinical pipeline report, company report or official report of Morphotek.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.

Drug Information